Search

everythinglearnresearchcommunity

for

Search:↓

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Baldness may lower the risk of testicular cancer.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

The document concludes that successful management of eyebrow and forehead ptosis requires a thorough approach, considering anatomy, patient evaluation, and careful selection of surgical techniques.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

Current research explores hair growth drugs, while future research aims for personalized treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Some antiepileptic drugs can cause weight gain and hair loss, especially in women.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

PFS affects some women, steroids easily bought online, hypogonadism info unreliable, low testosterone linked to CVD.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.